Medical Condition

alcohol use disorder

Total Trials

19

Recruiting Now

19

Trial Phases

Phase 2, Phase 1, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for alcohol use disorder sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — alcohol use disorder Clinical Trials

How many clinical trials are currently recruiting for alcohol use disorder?

ClinicalMetric currently tracks 19 actively recruiting clinical trials for alcohol use disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for alcohol use disorder?

alcohol use disorder research spans Phase 1 (3 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a alcohol use disorder clinical trial?

Eligibility criteria for alcohol use disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Yale University 3 trials

National Institute of Mental Health (NIMH) 2 trials

New York State Psychiatric Institute 1 trial

University of Rochester 1 trial

University of Illinois at Chicago 1 trial

alcohol use disorder

Frequently Asked Questions — alcohol use disorder Clinical Trials

Recruiting Clinical Trials

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT

StuDy AimED at Increasing AlCohol AbsTinEnce

Enhancing Prospective Thinking in Early Recovery (BEAM)

Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study

New Relapse Model in Psychiatry

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Promoting Alcohol Treatment Engagement Post-hospitalization

Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat

Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment

Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder

The Impact of Heavy Alcohol Use on Saliva and Oral Health

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

ACT_for Alcohol Use Disorder and Depression

Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer

Harmony: A Combined MI and BCT Intervention to Reduce Intimate Partner Violence and Alcohol Use in South India

Neural Correlates During Alcohol Intoxication

Translation and Validation of the COMM and ASI-SR

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)